KIORA PHARMACEUTICALS, INC. Capital Expenditures
KIORA PHARMACEUTICALS, INC. (KPRX) reported Capital Expenditures of $28.47 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-07
- KIORA PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $23.46K, a 27.14% decline year-over-year.
- KIORA PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $5.02K.
- KIORA PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $78.16K.
- KIORA PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $431.00.
- KIORA PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for fiscal 2025 was $110.79K, a 1670.92% increase from fiscal 2024.
- KIORA PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $6.26K.
- KIORA PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $0.00.
- KIORA PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $23.46K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $28.47K 10-Q · filed 2026-08-07 | $106.64K derived: sum of 3 quarters · filed 2026-08-07 | $107.07K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $5.02K 10-Q · filed 2026-05-08 | $83.18K derived: sum of 2 quarters · filed 2026-05-08 | $83.61K derived: sum of 3 quarters · filed 2026-05-08 | $115.81K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $78.16K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $78.59K derived: sum of 2 quarters · filed 2026-03-25 | $110.79K derived: sum of 3 quarters · filed 2026-08-07 | $110.79K 10-K · filed 2026-03-25 |
| 2025-09-30 | $431.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $32.63K derived: sum of 2 quarters · filed 2026-08-07 | $32.63K 10-Q · filed 2025-11-07 | -$12.40K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $32.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $32.20K 10-Q · filed 2026-08-07 | -$12.84K derived: sum of 3 quarters · filed 2026-08-07 | -$12.84K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-08 | -$45.03K derived: sum of 2 quarters · filed 2026-05-08 | -$45.03K derived: sum of 3 quarters · filed 2026-05-08 | |
| 2024-12-31 | -$45.03K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$45.03K derived: sum of 2 quarters · filed 2026-03-25 | $6.26K 10-K · filed 2026-03-25 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $51.29K 10-Q · filed 2025-11-07 | ||
| 2024-06-30 | $51.29K 10-Q · filed 2025-08-08 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | $0.00 derived: sum of 2 quarters · filed 2025-03-25 | $0.00 10-K · filed 2025-03-25 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $0.00 10-Q · filed 2024-11-08 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-09 | |||
| 2022-12-31 | $0.00 10-K · filed 2023-03-23 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $0.00 derived: sum of 2 quarters · filed 2023-03-23 | $5.75K derived: sum of 3 quarters · filed 2023-03-23 | $63.87K 10-K · filed 2023-03-23 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $5.75K derived: sum of 2 quarters · filed 2022-11-09 | $63.87K 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $5.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $63.87K 10-Q · filed 2022-08-12 | ||
| 2021-03-31 | $58.12K 10-Q · filed 2022-07-08 | |||
| 2020-12-31 | $20.08K 10-K/A · filed 2022-07-07 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $0.00 10-K · filed 2021-03-25 | ||
| 2019-09-30 | $0.00 10-Q · filed 2019-11-07 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04 | $20.00K 10-K · filed 2020-03-04 | ||
| 2018-09-30 | $20.00K 10-Q · filed 2019-11-07 | |||
| 2017-12-31 | $37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $37.00K 10-K · filed 2019-03-01 | ||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-13 | |||
| 2016-12-31 | $0.00 10-K · filed 2018-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |